Industry News
Pharmaceutical Industry News
The Promise and Risk of Biden’s War on Drug Prices
Lowering the prices of vital drugs is worthwhile, but innovation could suffer if the government isn’t careful.
A Major Overhaul of Prescription Drug Prices
A negotiation program is projected to save the government tens of billions of dollars in the coming years.
Republican Women, Fearing Backlash on Abortion, Pivot to Birth Control
A group of politically vulnerable G.O.P. women has backed legislation that purports to expand birth control access but would have little effect. Critics say the bill is meant to distract from their anti-abortion stances.
Biden Makes Lower Drug Prices a Centerpiece of His 2024 Campaign
President Biden’s Inflation Reduction Act allows Medicare to negotiate some drug prices, a change that the pharmaceutical industry and Republicans have opposed for decades.
Narcan Available for Over-the-Counter Purchase: What to Know
The overdose-reversal drug should be more widely available, health experts have said. It arrives in many stores next week, no prescription necessary.
Biden Administration Unveils First Drugs for Medicare Price Negotiations
The price negotiation program, established by Democrats as part of the Inflation Reduction Act, is projected to save the government tens of billions of dollars in the coming years.
Biden Administration Selects Drugs for Medicare Price Negotiations
After his administration announced the first set of medications selected for Medicare price negotiations, President Biden vowed to continue standing up to the pharmaceutical industry over the cost of drugs.
Ozempic and Wegovy, Novo Nordisk’s Weight Loss Drugs, Reshape Denmark’s Economy
Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of Denmark’s economic growth.
The N.Y.C. Neighborhood That’s Getting Even Thinner on Ozempic
Prescriptions for a new class of medications used for diabetes and weight loss are concentrated in the city’s wealthier, whiter and healthier neighborhoods.
New RSV Vaccines Aren’t Covered by Some Health Insurance Plans
The shot is covered by Medicare Part D, but some with private prescription drug coverage are being asked to pay out of pocket.
Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billion
Mallinckrodt Pharmaceuticals had promised $1.7 billion to governments, individuals and others harmed by the opioid crisis.
¿Por qué funcionan Ozempic y otros medicamentos para bajar de peso?
Se ha observado que algunos medicamentos como Ozempic ayudan a bajar de peso. Pero la ciencia aún no logra descubrir las razones de su eficacia.
Expert Panel Recommends New Drugs for HIV Prevention
The “grade A” endorsement means that two additional drugs should be covered under the Affordable Care Act.
RSV Vaccines: What to Know For Babies, Pregnant Women and Older Adults
New vaccines for older adults and an antibody therapy for infants provide options for preventing severe infection.
Where Ozempic, Wegovy and New Weight Loss Drugs Came From
The empty auditoriums, Gila monsters, resistant pharmaceutical executives and enigmas that led to Ozempic and other drugs that may change how society thinks about obesity.
Today’s Top News: The Search for Those Lost to Maui’s Fires, and More
Exclusively from New York Times Audio, our new app.
Utah Fugitive Accused of Selling Fake Covid-19 Cure Arrested
Gordon Hunter Petersen is accused of posing as a doctor and making at least $2 million selling a bogus Covid-19 cure.
ADHD Medication Shortage Continues as the School Year Begins
As a new school year begins, parents and doctors find medication shortages are leading to declines in learning and self-esteem.
Opioid Settlement Money Is Being Spent on Police Cars and Overtime
As states and counties spend the first wave of billions of dollars from the pharmaceutical industry, public health groups are challenging how some funds are being used.
Research Trials Halted at Columbia’s Psychiatric Center After Suicide
Human research trials at the New York State Psychiatric Institute at Columbia have been paused while regulators review whether protocols were violated.